Disorders of Sleep Part 1

Sleep and wakefulness are two basic biologic processes that have independent functions and controls. Sleep has been defined on the basis of behavioral criteria (e.g., lack of mobility or slight mobility, closed eyes, a markedly reduced response to external stimulation, a characteristic sleeping posture, and a reversibly unconscious state) and physiologic criteria (e.g., readings obtained by electroencephalography [EEG], electro-oculography [EOG], and electromyography [EMG]).1-3

The exact biologic functions of sleep are not known, although it is known that sleep is essential and that sleep deprivation leads to impaired attention and decreased performance, in addition to sleepiness. Sleep is believed to have restorative, conservative, adaptive, thermoregulatory, and consolidative functions. Sleep is also required for maintenance of synaptic and neuronal network integrity.1 The theory that memory reinforcement and consolidation take place during sleep has been strengthened by scientific data.4,5 Although the exact physiologic functions of dreaming are unknown, they may include activation of the neural networks of the brain, restructuring and reinterpretation of data stored in memory, and removal of unnecessary and useless information from the brain.

Primary care physicians should have a high index of suspicion for the presence of sleep disorders. Most sleep disorders, once recognized, can be managed with limited consultation. The initial step is to treat any condition that may be secondarily responsible for hypersomnia or insomnia. However, the treatment of primary sleep disorders is best handled by a sleep specialist.


Physiology of Sleep

Sleep architecture and stages

Sleep is divided into two independent states: non-rapid eye movement (NREM) sleep and rapid eye movement (REM) sleep. NREM sleep is further divided into four stages [see Non-Rapid Eye Movement Sleep, below], primarily on the basis of electroencephalographs criteria [see Figure 1a]; together, stage III and stage IV NREM sleep constitute slow wave sleep. NREM and REM sleep alternate, with each cycle lasting about 90 to 100 minutes. Four to six such cycles are noted during a normal sleep period. The first third of a normal sleep period is dominated by slow wave sleep (see below), and the last third is dominated by REM sleep.

Non-Rapid Eye Movement Sleep

In stage I NREM sleep, the alpha wave (8 to 13 Hz) rhythms characteristic of wakefulness diminish to less than 50% in an epoch (i.e., a 30-second segment of a polysomnography tracing with a speed of 10 mm/sec), and a mixture of slower rhythms called theta waves (4 to 7 Hz) appears; EMG activity decreases slightly, and slow, rolling eye movements may be apparent [see Figure 1b]. Toward the end of stage I NREM sleep, vertex sharp waves appear. In normal persons, stage II NREM sleep begins after about 10 to 12 minutes of stage I NREM sleep. The characteristic EEG features of stage II NREM sleep are sleep spindles (12 to 18 Hz, most often 14 Hz) and K complexes intermixed with vertex sharp waves [see Figure 1c]. The background rhythms of stage II NREM sleep consist of theta waves and delta waves (< 4 Hz). Less than 20% of the epoch is occupied by delta waves. Stage II NREM sleep lasts for about 30 to 60 minutes. During stage III NREM sleep, the delta waves occupy 20% to 50% of the epoch [see Figure 1d], and during stage IV NREM sleep, the delta waves occupy more than 50% of the epoch [see Figure 1e].

Human sleep and wakefulness stages are characterized by readings obtained by electroencephalography (EEG), electro-oculography (EOG), and electromyography (EMG). (a) An EEG tracing shows the alpha wave (9 to 10 Hz) activity representative of wakefulness in adults. (b) Stage I non-rapid eye movement (NREM) sleep is characterized by low-amplitude theta wave (4 to 7 Hz) activity mixed with a small amount (< 50%) of alpha wave activity and vertex sharp waves in the EEG tracing; slow, rolling movements in right and left eye EOG recordings; and tonic chin EMG activity. (c) EEG tracings of stage II NREM show sleep spindles. (d) EEG tracings reveal that in stage III NREM sleep, 20% to 50% of an epoch is occupied by waves of 2 Hz or less with an amplitude of greater than 75 mV. (e) In stage IV NREM sleep, these waves make up more than 50% of an epoch. Together, stages III and IV constitute slow wave sleep. (f REM sleep is characterized on EEG tracings by low-amplitude mixed-frequency theta wave and beta wave (> 13 Hz) activity, including a small amount of alpha waves without sleep spindles or K complexes. Rapid eye movements are seen in the EOG readouts. The chin EMG shows marked reduction or absence of tonic activity.

Figure 1 Human sleep and wakefulness stages are characterized by readings obtained by electroencephalography (EEG), electro-oculography (EOG), and electromyography (EMG). (a) An EEG tracing shows the alpha wave (9 to 10 Hz) activity representative of wakefulness in adults. (b) Stage I non-rapid eye movement (NREM) sleep is characterized by low-amplitude theta wave (4 to 7 Hz) activity mixed with a small amount (< 50%) of alpha wave activity and vertex sharp waves in the EEG tracing; slow, rolling movements in right and left eye EOG recordings; and tonic chin EMG activity. (c) EEG tracings of stage II NREM show sleep spindles. (d) EEG tracings reveal that in stage III NREM sleep, 20% to 50% of an epoch is occupied by waves of 2 Hz or less with an amplitude of greater than 75 mV. (e) In stage IV NREM sleep, these waves make up more than 50% of an epoch. Together, stages III and IV constitute slow wave sleep. (f REM sleep is characterized on EEG tracings by low-amplitude mixed-frequency theta wave and beta wave (> 13 Hz) activity, including a small amount of alpha waves without sleep spindles or K complexes. Rapid eye movements are seen in the EOG readouts. The chin EMG shows marked reduction or absence of tonic activity.

Rapid Eye Movement Sleep

Sixty to 90 minutes after the onset of sleep, the first REM sleep episode is noted. The EEG tracings during REM sleep are characterized by fast rhythms and theta wave activities, some of which may have a sawtooth appearance [see Figure 1f]. The hallmark of REM sleep is the presence of rapid eye movements in all directions and the marked diminution or absence of muscle activities in the chin EMG. Tonic REM sleep is characterized by a desyn-chronized EEG and muscle atonia, and phasic REM sleep is characterized by REMs as well as phasic swings in blood pressure and heart rate, irregular respiration, and phasic tongue movements. A few periods of apnea or hypopnea may arise during REM sleep.

Sleep patterns across the lifespan

Sleep requirements change dramatically from infancy to old age. Newborns have a polyphasic sleep pattern, with a total of 16 hours of sleep a day. By the time a child is 3 to 5 years of age, the sleep requirement falls to about 10 hours a day. In preschool children, sleep assumes a biphasic pattern. Adults exhibit a monopha-sic sleep pattern, with an average duration of 7.5 to 8.0 hours a night, but the pattern reverts to biphasic in elderly persons.

In newborn infants, the amount of sleep time spent in the REM state is about 50%, but by 6 years of age, REM sleep has decreased to the normal adult pattern of 25%. By 3 months of age, the NREM-REM cyclic pattern of adult sleep is established and sleep spindles appear. K complexes are first seen in infants at about 6 months of age. Attenuation of the amplitude of delta waves and repeated awakenings—including early morning awakenings—are important features of sleep in elderly persons.

Functional neuroanatomy

The neuroanatomic substrates for REM sleep and NREM sleep are located in separate parts of the central nervous sys-tem.2,6 REM sleep is generated by neurons in the pontomesencephalic region.6,7 The cells that activate REM sleep are choliner-gic neurons located in the pedunculopontine tegmental nucleus and the laterodorsal tegmental nucleus in the pontomesen-cephalic region; these cells fire maximally during REM sleep. The cells that deactivate REM sleep are aminergic neurons located in the locus coeruleus and raphe nuclei; these cells are inactive during REM sleep. A reciprocal interaction in the brain stem between REM-activating and REM-deactivating neurons is responsible for REM generation and maintenance.

The active hypnogenic neurons for NREM sleep are located primarily in the preoptic area of the hypothalamus, the basal forebrain area, and the solitary nucleus region of the medulla. The reticular nucleus of the thalamus is thought to be responsible for sleep spindle generation.

Sleep most likely results from both passive and active mecha-nisms.6 Muscle hypotonia during REM sleep is thought to depend on the inhibitory postsynaptic potentials generated by dorsal pontine descending axons.8,9 The roles of neurotransmitters and neuropeptides are not clearly delineated; they are believed to modulate various sleep stages and cycles. It has been shown that adenosine may fulfill the major criteria for neural sleep factor, which mediates the somnogenic effects of prolonged wakefulness.

Table 1 Behavioral and Physiologic Characteristics of States of Awareness

Characteristics

Awake

NREM Sleep

REM Sleep

tmp5F-40

Posture

Erect, sitting, or recumbent

Recumbent

Recumbent

Mobility

Normal

Mildly reduced to absent;

Moderately reduced to absent; myoclonic jerks

postural shifts

Response to stimulation

Normal

Mildly to markedly reduced

Moderately reduced to absent

Alertness level

Alert

Reversibly unconscious

Reversibly unconscious

Eye position and movements

Open

Closed

Closed

WEMs

SEMs

REMs

tmp5F-41

EEG

Alpha waves Desynchronized

Synchronized

Theta or sawtooth waves Desynchronized

EMG (muscle tone)

Normal

Mildly reduced

Moderately to severely reduced or absent

EOG

WEMs

SEMs

REMs

Heart rate

Normal sinus rhythm

Bradycardia

Bradytachyarrhythmia

Blood pressure

Normal

Decreases

Variable

Cardiac output

Normal

Decreases

Decreases further

Respiratory rate

Normal

Decreases

Variable

Apneas may occur

Alveolar ventilation

Normal

Decreases

Decreases further

Upper airway muscle tone

Normal

Mildly reduced

Moderately to markedly reduced or absent

Upper airway resistance

Normal

Moderately increased

Markedly increased

Cerebral blood flow

Normal

Decreased or normal

Markedly increased

Parasympathetic activity

Normal

Moderately increased

Markedly increased

Sympathetic activity

Normal

Mildly reduced

Moderately to markedly reduced or variable

Penile or clitoral tumescence

Normal

Normal

Markedly increased

Thermoregulation

Normal

Mildly reduced

Absent

NREM—non-rapid eye movement

REM—rapid eye movement

SEM—slow eye movement

WEM—waking eye movement

The recently described hypocretin (orexin) peptidergic system, which is located in the lateral hypothalamic region and peri-fornical area and has widespread ascending and descending projections, is thought to play a role in the control of sleep and wakefulness.11-13 Sleepiness may be induced by reduction of activity of the hypocretin projections to the locus coeruleus; mid-line raphe; and the mesopontine, posterior hypothalamic, and tuberomammillary regions.

Physiologic changes during sleep

A variety of behavioral and physiologic changes occur during normal wakefulness, NREM sleep, and REM sleep [see Table 1]. These changes are most commonly noted in the somatic and au-tonomic nervous systems (ANS); in the respiratory, cardiovascular, and gastrointestinal systems; in endocrine, renal, and sexual function; and in thermoregulation.2,14 The fundamental changes in the ANS consist of an increase in the parasympathetic tone and a decrease in sympathetic activity during NREM sleep, with further increase of parasympathetic tone and decrease in sympathetic activity during REM sleep. During the REM sleep phase, however, sympathetic activity increases intermittently. Sympathetic nerve activity in muscle and the vascular beds of the skin, as measured by microneurographic technique, is reduced during NREM sleep but is increased during REM sleep.

During both NREM and REM sleep, the respiratory neurons in the pontomedullary region show a decreased firing rate. Muscle tone in the upper airway decreases in NREM sleep and disappears in REM sleep, resulting in an increase in upper airway resistance. Two separate systems—the metabolic (or automatic) and voluntary (or behavioral) systems—control respiration during sleep and wakefulness. Both the metabolic and the voluntary system operate during wakefulness, whereas only the metabolic system operates during NREM sleep. The wakefulness stimuli that act through the ascending reticular activating system also act as tonic stimuli to ventilation. Hypercapnic and hypoxic ven-tilatory responses are moderately reduced in NREM sleep but are more markedly decreased during REM sleep. Tidal volume and alveolar ventilation decrease during sleep; arterial oxygen tension is mildly decreased and arterial carbon dioxide tension is increased during both NREM and REM sleep. Thus, respiration is vulnerable during normal sleep, and a few periods of apnea may occur, especially at the onset of sleep and during REM sleep. Heart rate, blood pressure, cardiac output, and peripheral vascular resistance decrease during NREM sleep and decrease still further during REM sleep. Cerebral blood flow and cerebral metabolic rates for glucose and oxygen decrease during NREM sleep but increase to above waking values during REM sleep.

Profound changes in endocrine secretions are registered during sleep. Growth hormone secretion exhibits a pulsatile increase during NREM sleep in the first third of the normal sleep period. Prolactin secretion also rises 30 to 90 minutes after the onset of sleep. Sleep inhibits cortisol secretion. Secretion of thyroid-stimulating hormone reaches a peak in the evening and then decreases throughout the night. Testosterone levels in men increase during sleep, rising from trough levels at 8 P.M. to peak levels at 8 A.M., but no clear relation has been demonstrated between levels of gonadotropic hormones and the sleep-wake cycle in children or adults. Melatonin, which is released by the pineal gland, attains its highest secretion level between 3 A.M. and 5 A.M., then decreases to low levels during the day.

Body temperature begins to fall at the onset of sleep and reaches its lowest point during the third sleep cycle. Thermoreg-ulation is maintained during NREM sleep but is nonexistent in REM sleep. Penile erection and clitoral tumescence occur during REM sleep.

Circadian rhythms

Circadian means a period of about 24 hours; however, the human circadian rhythm cycle is about 25 hours. The existence of circadian rhythms has been known since 1731, when the French astronomer J. J. D. de Mairan noted a circadian rhythm in a plant.16 The suprachiasmatic nucleus of the hypothalamus is thought to be the site of this biologic clock. The body temperature rhythm closely follows the circadian rhythm of sleep and wakefulness but is independent of it. Dysfunction of circadian rhythms results in some important human sleep disorders.17

General Approach to Disorders of Sleep

Sleep complaints are very common in the general population. According to the report of the National Center on Sleep Disorders Research, more than 40 million persons in the United States suffer from chronic disorders of sleep and wakefulness.18

Classification

The second edition of the International Classification of Sleep Disorders (ICSD-2) lists eight categories of sleep disorders.

Diagnosis

Clinical Manifestations

The four major sleep-related complaints for which patients seek medical attention are excessive daytime somnolence (EDS), insomnia, abnormal movements or behavior during sleep, and an inability to sleep at the desired time. Insomnia patients may complain of some or all of the following: difficulty initiating or maintaining sleep, repeated awakenings or early morning awakenings, nonrestorative sleep, daytime fatigue, lack of concentration, irritability, anxiety, depression, and muscle aches and pains. Insomnia may be idiopathic (i.e., no cause is found) or co-morbid with other conditions [see Table 3]. Patients with hyper-somnia may complain of EDS, a lack of relief of symptoms after additional nighttime sleep, inability to concentrate, and impaired cognition and motor skills. The most common cause of EDS is behaviorally induced insufficient sleep syndrome (sleep deprivation) [see Table 2]. Some patients with restless legs syndrome (RLS), periodic limb movements in sleep (PLMS), or cir-cadian rhythm sleep disorders may also experience hypersom-nolence in the daytime.

The first step in assessing a patient with a sleep disturbance is obtaining a history, which should include a family history and directed inquiries on sleeping habits, drug and alcohol consumption, and previous or current psychiatric, medical, and neurologic illnesses. Diagnostic tests must be confirmatory and subservient to the clinical history and physical examination. Electrophysiologic investigation of patients with suspected sleep disorders is resource intensive and is best planned in consultation with a sleep specialist.

Table 2 International Classification of Sleep Disorders, Second Edition17

Insomnia

Other sleep-related breathing disorder

Acute insomnia

Sleep apnea/sleep-related breathing disorder, unspecified

Psychophysiologic insomnia

Paradoxical insomnia (sleep-state misperception)

Hypersomnias of Central Origin Not Due to a Circadian Rhythm Sleep Disorder, Sleep-Related Breathing Disorder, or Other Cause of Disturbed

Idiopathic insomnia

Nocturnal Sleep

Insomnia due to mental disorder

Narcolepsy with cataplexy

Inadequate sleep hygiene

Narcolepsy without cataplexy

Behavioral insomnia of childhood

Narcolepsy due to medical condition

Insomnia due to drug or substance

Narcolepsy, unspecified

Insomnia due to medical condition

Recurrent hypersomnia

Insomnia not due to substance or known physiologic condition, unspecified (nonorganic)

Kleine-Levin syndrome

Physiologic insomnia, unspecified (organic)

Menstrual-related hypersomnia

Idiopathic hypersomnia with long sleep time

Sleep-Related Breathing Disorders

Idiopathic hypersomnia without long sleep time

Central sleep apnea syndromes

Behaviorally induced insufficient sleep syndrome

Primary central sleep apnea

Hypersomnia due to medical condition

Central sleep apnea due to Cheyne-Stokes breathing pattern

Hypersomnia due to drug or substance

Central sleep apnea due to high-altitude periodic breathing

Hypersomnia not due to substance or known physiologic condition (nonorganic hypersomnia, not otherwise specified [NOS])

Central sleep apnea due to medical condition not Cheyne-Stokes

Physiologic (organic) hypersomnia, unspecified (organic

Central sleep apnea due to drug or substance

hypersomnia, NOS)

Primary sleep apnea of infancy (formerly primary sleep apnea of newborn)

Circadian Rhythm Sleep Disorders

Obstructive sleep apnea syndromes

Circadian rhythm sleep disorder, delayed-sleep-phase type (delayed-sleep-phase disorder)

Obstructive sleep apnea, adult

Obstructive sleep apnea, pediatric

Circadian rhythm sleep disorder, advanced-sleep-phase type (advanced-sleep-phase disorder)

Sleep-related hypoventilation/hypoxemic syndromes

Sleep-related nonobstructive alveolar hypoventilation, idiopathic

Circadian rhythm sleep disorder, irregular sleep-wake type (irregular sleep-wake rhythm)

Congenital central alveolar hypoventilation syndrome

Circadian rhythm sleep disorder, free-running type (nonentrained type)

Sleep-related hypoventilation/hypoxemia due to medical condition

Circadian rhythm sleep disorder, jet-lag type (jet-lag disorder)

Sleep-related hypoventilation/hypoxemia due to pulmonary parenchymal or vascular pathology

Circadian rhythm sleep disorder, shift work type (shift-work disorder)

Circadian rhythm sleep disorder due to medical condition

Sleep-related hypoventilation/hypoxemia due to lower airway obstruction

Other circadian rhythm sleep disorder (circadian rhythm disorder, NOS)

Sleep-related hypoventilation/hypoxemia due to neuro-muscular and chest wall disorders

Other circadian rhythm sleep disorder due to drug or substance

Laboratory Studies

The two most important laboratory tests for sleep disorders are the all-night polysomnography (PSG) study and the Multiple Sleep Latency Test (MSLT). All-night PSG studies simultaneously record several physiologic variables (i.e., EEG, EMG, EOG, electrocardiography, airflow at the nose and mouth, respiratory effort, and oxygen saturation) and are important in confirming a diagnosis of EDS or obstructive sleep apnea syndrome (OSAS), as well as documenting the severity of sleep apnea, hypoxemia, and sleep fragmentation. Overnight PSG determines the optimal pressure for continuous positive airway pressure (CPAP)—a treatment for OSAS—and is also helpful for supporting the diagnosis of narcolepsy and the parasomnias. Overnight PSG with simultaneous video recording can confirm REM sleep behavior disorder (RBD) and is particularly useful for the documentation of unusual movements and behavior during nighttime sleep in patients with parasomnias and nocturnal seizures.

The MSLT is essential in documenting pathologic sleepiness (e.g., sleep-onset latency of less than 5 minutes)19 and in diagnosing narcolepsy. The presence of two sleep-onset REMs on four or five nap studies and sleep-onset latency of less than 8 minutes strongly suggest a diagnosis of narcolepsy.

Another important laboratory test for assessing sleep disorders is actigraphy.20 This technique utilizes an actigraph (also known as an actometer) worn on the wrist or ankle to record acceleration or deceleration of body movements, which indirectly indicates sleep-wakefulness. Actigraphy for days or weeks is a useful laboratory test in patients with insomnia and circadian rhythm sleep disorders, as well as in some patients with prolonged daytime sleepiness.

Magnetic resonance imaging studies and other neuroimaging techniques should be performed to exclude structural neurologic lesions. Appropriate laboratory tests should always be performed to exclude any suspected medical disorders that may be the cause of the patient’s insomnia or hypersomnia.

Specific Disorders of Sleep

Obstructive sleep apnea syndrome

Apnea, or cessation of breathing during sleep, consists of three types: central, obstructive, and mixed.2 In central apnea, both the airflow at the upper airway (e.g., pharynx and nose) and the effort by the diaphragm and other respiratory muscles cease. By contrast, during obstructive apnea, the airflow stops while the effort continues [see Figure 2]. In mixed apnea, an initial period of central apnea is followed by a period of obstructive apnea. The most common type of apnea is OSAS.21 Sleep hypopnea, defined as a decrease of breathing to half the volume measured during the preceding or following respiratory cycle accompanied by an arousal or oxygen desat-uration of 3% to 4% or more, has the same significance as ap-nea.2,21 To qualify as pathologic sleep apnea or hypopnea, the decreased breathing must last for at least 10 seconds and the apnea-hypopnea index or respiratory disturbance index (i.e., the number of episodes of apnea-hypopnea per hour of sleep) must be at least five.

Table 2

Parasomnias

Snoring

Disorders of arousal (from non-rapid eye movement [REM]

Sleep talking

sleep)

Sleep starts (hypnic jerks)

Confusional arousals

Benign sleep myoclonus of infancy

Sleepwalking

Hypnagogic foot tremor and alternating leg muscle activation

Sleep terrors

during sleep

Parasomnias usually associated with REM sleep

Propriospinal myoclonus at sleep onset

REM sleep behavior disorder (including parasomnia overlap disorder and status dissociates)

Excessive fragmentary myoclonus

Recurrent isolated sleep paralysis

Other Sleep Disorders

Nightmare disorder

Other physiologic (organic) sleep disorder

Other parasomnias

Other sleep disorder not due to substance or known physio-

Sleep-related dissociative disorders

logic condition

Sleep enuresis

Environmental sleep disorder

Sleep-related groaning (catathrenia)

Sleep Disorders Associated with Conditions Classifiable Elsewhere

Exploding head syndrome

Fatal familial insomnia

Sleep-related hallucinations

Sleep-related eating disorders

Fibromyalgia

Parasomnia, unspecified

Sleep-related epilepsy

Parasomnia due to drug or substance

Sleep-related headaches

Parasomnia due to medical condition

Sleep-related gastroesophageal reflux disease

Sleep-Related Movement Disorders

Sleep-related coronary artery ischemia

Restless legs syndrome

Sleep-related abnormal swallowing, choking, and laryn-

Periodic limb movement disorder

gospasm

Sleep-related leg cramps

Other Psychiatric and Behavioral Disorders Frequently Encountered in the

Sleep-related bruxism

Differential Diagnosis of Sleep Disorders

Sleep-related rhythmic movement disorder

Mood disorders

Sleep-related movement disorder, unspecified

Anxiety disorders

Sleep-related movement disorder due to drug or substance

Somatoform disorders

Sleep-related movement disorder due to medical condition

Schizophrenia and other psychotic disorders

Isolated Symptoms, Apparently Normal Variants, and Unresolved Issues

Disorders usually first diagnosed in infancy, childhood, or

Long sleeper

adolescence

Short sleeper

Personality disorders

OSAS is common in middle-aged and elderly men. An important study indicated a prevalence of 4% in men and 2% in women between 30 and 60 years of age.22 In women, the incidence of OSAS is greater after menopause. The pathogenesis of OSAS includes local anatomic factors (e.g., narrowing of the upper airway and excessive relaxation of the upper airway muscles during sleep, with increased upper airway resistance) and neurologic factors that may cause dysfunction of the respiratory neurons in the brain stem [see 14:VI Ventilatory Control during Wakefulness and Sleep].

Next post:

Previous post: